Phase IIIPeptide
Compound 61880
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061880
Risk Class
HIGH
Last Audit
Sep 17, 2108
Research Abstract
Peptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61880 is a peptide asset inside peptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase iii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061880 with updates logged 2108-09-17.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61880Peptide Program 61880
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061880
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61880